1. AB0561 Needs-Assessment Survey for the Update of the Current Antiphospholipid Syndrome (APS) Classification Criteria. (9th June 2015) Authors: Barbhaiya, M.; Abreu, M.; Amigo, M.C.; Avcin, T.; Bertolaccini, M.L.; Branch, W.; de Groot, P.G.; de Jesus, G.; Levy, R.; Lockshin, M.; Tektonidou, M.; Wahl, D.; Willis, R.; Zuily, S.; Costenbader, K.; Erkan, D. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB1071 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Core Laboratory Validation Exercise: Comparison of Chemiluminescence Immunoassay (CIA) and Enzyme-Linked Immunosorbant Assay (ELISA). (9th June 2015) Authors: Bertolaccini, M.L.; Willis, R.; Lakos, G.; Andrade, D.; Pengo, V.; Banzato, A.; Krilis, S.; Erkan, D. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0425 The Global Antiphospholipid Syndrome Score (GAPSS) Differentiates Between Transient Ischemic Attack and Stroke in Patients with Antiphospholipid Antibodies. (9th June 2015) Authors: Sciascia, S.; Sanna, G.; Murru, V.; Roccatello, D.; Khamashta, M.; Bertolaccini, M.L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0223 Significance of IGG Phosphatidylserine-Dependent Antiprothrombin Antibody Testing for the Diagnosis of Antiphospholipid Syndrome: Results from the Initial and Validation International Multi-Centre Studies. (9th June 2015) Authors: Amengual, O.; Forastiero, R.; Sugiura-Ogasawara, M.; Otomo, K.; Kenji, O.; Favas, C.; Delgado Alves, J.; Žigon, P.; Ambrožič, A.; Tomšič, M.; Ruiz Arruza, I.; Ruiz Irastorza, G.; Bertolaccini, M.L.; Norman, G.L.; Shums, Z.; Jiro, A.; Murashima, A.; Tebo, A.E.; Gerosa, M.; Meroni, P.L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0161 Fluvastatin treatment prevents the inflammatory/oxidative status linked to the clinical activity of the disease in systemic lupus erythematosus patients. (23rd January 2014) Authors: Ruiz-Limon, P.; Perez-Sanchez, C.; Aguirre, M.A.; Bertolaccini, M.L.; Carretero, R.M.; Rodriguez-Ariza, A.; Barbarroja, N.; Khamashta, M.; Collantes-Estevez, E.; Cuadrado, M.J.; Lopez-Pedrera, C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0202 International Multi-Centre Study to Evaluate the Clinical Significance of Phosphatidylserine-Dependent Antiprothrombin Antibodies for the Diagnosis of Antiphospholipid Syndrome. (10th June 2014) Authors: Amengual, O.; Forastiero, R.; Sugiura-Ogasawara, M.; Oku, K.; Otomo, K.; Alves, J.; Favas, C.; Žigon, P.; Ambrožič, A.; Tomšič, M.; Ruiz-Irastorza, G.; Ruiz-Arruza, I.; Bertolaccini, M.L.; Norman, G.L.; Shums, Z.; Arai, J.; Atsumi, T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗